Xponance, Inc.

SEC CIK: 0001637541
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

EW holding history

Edwards Lifesciences Corp in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overview All 13F holders of EW Full Q2 2026 holdings

Shares (Q2 2026): 102,830
Value: $9.30M
% of portfolio: 0.1%
Quarters held: 22; Since Q1 2021

Holdings of EW by Xponance, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	102,830	$9.30M	0.1%	−2,208−2.1%	Reduced	Holders
Q1 2026	105,038	$8.41M	0.1%	+16,908+19.2%	Added	Holders
Q4 2025	88,130	$7.51M	0.1%	+5,005+6.0%	Added	Holders
Q3 2025	83,125	$6.46M	0.1%	−3,659−4.2%	Reduced	Holders
Q2 2025	86,784	$6.79M	0.1%	−7,934−8.4%	Reduced	Holders
Q1 2025	94,718	$6.87M	0.1%	−370−0.4%	Reduced	Holders
Q4 2024	95,088	$7.04M	0.1%	+1,675+1.8%	Added	Holders
Q3 2024	93,413	$6.16M	0.1%	+1,120+1.2%	Added	Holders
Q2 2024	92,293	$8.53M	0.1%	−46,106−33.3%	Reduced	Holders
Q1 2024	138,399	$13.2M	0.1%	−578−0.4%	Reduced	Holders
Q4 2023	138,977	$10.6M	0.1%	−2,186−1.5%	Reduced	Holders
Q3 2023	141,163	$9.78M	0.1%	+2,273+1.6%	Added	Holders
Q2 2023	138,890	$13.1M	0.2%	−387−0.3%	Reduced	Holders
Q1 2023	139,277	$11.5M	0.2%	+2,379+1.7%	Added	Holders
Q4 2022	136,898	$10.2M	0.2%	+9,334+7.3%	Added	Holders
Q3 2022	127,564	$10.5M	0.2%	+2,265+1.8%	Added	Holders
Q2 2022	125,299	$11.9M	0.2%	−10,586−7.8%	Reduced	Holders
Q1 2022	135,885	$16.0M	0.3%	+1,395+1.0%	Added	Holders
Q4 2021	134,490	$17.4M	0.3%	+9,052+7.2%	Added	Holders
Q3 2021	125,438	$14.2M	0.3%	−2,995−2.3%	Reduced	Holders
Q2 2021	128,433	$13.3M	0.2%	−4,270−3.2%	Reduced	Holders
Q1 2021	132,703	$11.1M	0.2%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.